COMMUNIQUÉ DE PRESSE
News
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site
MIRA Pharmaceuticals progresses towards clinical-stage status with Phase I/IIa trial announcement on Ketamir-2, a novel oral ketamine analog, for pain management. CHDR's PainCart technology leveraged -
COMMUNIQUÉ DE PRESSE
Datametrex Announces AI and Tech Purchase Order (P.O.)
Datametrex AI Limited receives high margin purchase orders with $500K revenue and $300K expenses, resulting in 40% gross profit margin. The company's successful financial performance showcases its capacity to excel in a competitive market environment -
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Vulcan Energy Resources Limited: Vulcan and BASF announce partnership to reduce CO2 emissions at world’s largest integrated chemical complex
Vulcan Energy and BASF partner to reduce CO2 emissions at chemical complex through renewable heat and lithium production. Geothermal exploration funded by BASF
